INulin-type Fructans-induced Gut Microbiota Modulation Impact on GUT-SKIN Axis Parameters in Psoriasis

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 2, 2023

Primary Completion Date

June 28, 2024

Study Completion Date

June 28, 2024

Conditions
Psoriasis
Interventions
DIETARY_SUPPLEMENT

Chicory-derived inulin-type β-fructans

This supplement will be portioned into moisture-impermeable sachets containing 7.5 grams of prebiotic. During the first two weeks, to avoid eventual side effects, PS participants will be advised to consume the contents of one sachet at breakfast only. Starting in week 3 until the end of the 8-weeks intervention the participants will consume the content of two sachets daily (at breakfast and at dinner) resulting in a total dose of 15 grams of prebiotic per day. Participants will be provided with a package of sachets in the amount required for the whole 8-weeks nutritional intervention. They will be instructed to dissolve the sachet content with water or juice and to drink it 15-20 minutes prior to their regular meal. The medium for suspending the supplement (water or juice) could be chosen by the participants and could be changed during the study.

DIETARY_SUPPLEMENT

Maltodextrin

This supplement will be portioned into moisture-impermeable sachets containing 7.5 grams of maltodextrin. During the first two weeks, to avoid eventual side effects, PS participants will be advised to consume the contents of one sachet at breakfast only. Starting in week 3 until the end of the 8-week intervention the participants will consume the content of two sachets daily (at breakfast and at dinner) resulting in a total dose of 15 grams of placebo per day. Participants will be provided with a package of sachets in the amount required for the whole 8-weeks nutritional intervention. They will be instructed to dissolve the sachet content with water or juice and to drink it 15-20 minutes prior to their regular meal. The medium for suspending the supplement (water or juice) could be chosen by the participants and could be changed during the study.

Trial Locations (2)

10-229

Chair and Clinic of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, Municipal Hospital Complex, al. Wojska Polskiego 30, Olsztyn

10-748

Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, ul. Tuwima 10, Olsztyn

All Listed Sponsors
collaborator

University of Warmia and Mazury

OTHER

collaborator

Warsaw University of Life Sciences

OTHER

lead

Polish Academy of Sciences

OTHER